Systemic inflammation caused by an intracranial mesenchymal tumor with a EWSR1::CREM fusion presenting associated with IL‐6/STAT3 signaling
- 3 November 2022
- journal article
- research article
- Published by Wiley in Neuropathology
- Vol. 43 (3) , 244-251
Abstract
Pediatric neoplastic diseases account for about 10% of cases of fever of unknown origin (FUO), and most neoplastic disease cases are leukemia, lymphoma, and neuroblastoma. Brain tumors are rarely reported as the cause of FUO, although craniopharyngioma, metastatic brain tumor, and Castleman's disease have been reported. We report a case of intracranial mesenchymal tumor (IMT) with a FET:CREB fusion gene, which had inflammatory phenotype without neurological signs. A 10-year-old girl was admitted with a 2-month history of intermittent fever and headache, whereas her past history as well as her family history lacked special events. Sepsis work-up showed no pathological organism, and empirical antibiotic therapy was not effective. Bone marrow examination showed a negative result. Cerebrospinal fluid examination showed elevated protein as well as cell counts, and head magnaetic resonance imaging showed a hypervascular mass lesion with contrast enhancement in the left cerebellar hemisphere. The patient underwent tumor excision, which made the intermittent fever disappear. Pathological examinations resembled those of classic angiomatoid fibrous histiocytoma (AFH), but the morphological features were distinct from the AFH myxoid variant; then we performed break-apart fluorescence in situ hybridization and confirmed the tumor harbored the rare EWSR1::CREM fusion gene (Ewing sarcoma breakpoint region 1 gene (EWSR1) and cAMP response element binding (CREB) family gene). Consequently, we diagnosed the condition as IMT with EWSR1::CREM fusion. Elevated serum concentration of interleukin 6 (IL-6) was normalized after tumor resection, which suggested the fever could be caused by tumor-derived IL-6. This is the first case of IMT with EWSR1::CREM fusion that showed paraneoplastic symptoms associated with the IL-6/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Although brain tumors are rarely diagnosed as a responsible disease for FUO, they should be considered as a cause of unknown fever even in the absence of abnormal neurological findings.Keywords
Funding Information
- Ishibashi Foundation
- Daiichi Sankyo Company
This publication has 32 references indexed in Scilit:
- Intraventricular chordoid meningioma in a child: fever of unknown origin, clinical course, and response to treatmentJournal of neurosurgery. Pediatrics, 2012
- National survey of childhood febrile illness cases with fever of unknown origin in JapanPediatrics International, 2011
- Angiomatoid fibrous histiocytoma: unusual sites and unusual morphologyLaboratory Investigation, 2011
- Fever of unknown origin in children: a systematic reviewWorld Journal of Pediatrics, 2010
- Clear cell meningioma causing Castleman syndrome in a childJournal of neurosurgery. Pediatrics, 2010
- Fever of Unknown Origin: Clinical Overview of Classic and Current ConceptsInfectious Disease Clinics of North America, 2007
- Presentation of childhood CNS tumours: a systematic review and meta-analysisThe Lancet Oncology, 2007
- Intraventricular chordoid meningioma presenting with Castleman disease due to overproduction of interleukin-6Journal of Neurosurgery, 2005
- STAT3 is enriched in nuclear bodiesJournal of Cell Science, 2004
- FEVER OF UNEXPLAINED ORIGIN: REPORT ON 100 CASESMedicine, 1961